Delivery Order SPE2DR25D2003-SPE2DR26FQ99Q
- Not listed
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,743.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of October 29, 2025. This competitively awarded contract, issued without set-aside provisions, leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,660.42 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency has awarded a delivery order valued at $1,694.39 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed price, competitively awarded contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.00 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of December 5, 2025. This firm fixed price contract was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order transaction under AmerisourceBergen's larger contract vehicle with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,167.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on May 14, 2025, with completion targeted for May 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical and medical supply relationship with DLA. The sensors will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal healthcare procurement needs. This award...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FQ99QDelivery Order
The Defense Logistics Agency awarded a $1,248 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of December 2, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has been selected to supply Dexcom G7 continuous glucose monitoring sensors through the DLA's medical supply chain to support federal healthcare needs, including military and veteran systems. The Dexcom G7 is a critical diabetes management device used across Department of Defense medical facilities. This delivery order exemplifies AmerisourceBergen's role as a comprehensive federal medical vendor, capable of delivering specialized medical devices and pharmaceuticals through the DLA's competitive procurement process.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/30/25 |